Selvita Team Grows to Over 250 People
News Aug 11, 2015
Selvita has been intensively expanding its operations. The total employment at Selvita increased to 261 people, including 86 PhDs in August.
The period of 2014-2015 marks a significant increase for Selvita in terms of revenue and operations, both in its drug discovery outsourcing segment as well in the internal pipeline.
The company has recently signed several large and long-term services contracts in the area of medicinal and analytical chemistry with some of the most renowned pharma companies.
Selvita has also been successively expanding its capabilities in terms of proteomics, which has effected in establishing new collaborations also in this area.
The employment has been increasing accordingly, from 173 people in 2013, to 230 at the end of 2014.
Selvita is continuously investing in new laboratory infrastructure and highly qualified scientific staff, aiming to provide best quality integrated drug discovery services to pharmaceutical and biotechnology companies.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
Understanding Lung Cancer Cell Networks Helps Create Drug TreatmentsNews
A team of scientists has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.READ MORE
Comments | 0 ADD COMMENT
International Conference on Nanomedicine and Nanotechnology
Aug 20 - Aug 21, 2018